- Home
- MRBK vs INO Comparison
MRBK vs INO Comparison
Compare MRBK & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- INO
- Stock Information
- Founded
- MRBK 2004
- INO 1979
- Country
- MRBK United States
- INO United States
- Employees
- MRBK N/A
- INO N/A
- Industry
- MRBK Major Banks
- INO Medical/Dental Instruments
- Sector
- MRBK Finance
- INO Health Care
- Exchange
- MRBK Nasdaq
- INO Nasdaq
- Market Cap
- MRBK 162.3M
- INO 136.6M
- IPO Year
- MRBK 2017
- INO 1998
- Fundamental
- Price
- MRBK $14.74
- INO $2.61
- Analyst Decision
- MRBK Buy
- INO Buy
- Analyst Count
- MRBK 2
- INO 5
- Target Price
- MRBK $17.50
- INO $8.80
- AVG Volume (30 Days)
- MRBK 53.9K
- INO 1.0M
- Earning Date
- MRBK 10-23-2025
- INO 11-10-2025
- Dividend Yield
- MRBK 3.38%
- INO N/A
- EPS Growth
- MRBK 75.95
- INO N/A
- EPS
- MRBK 1.77
- INO N/A
- Revenue
- MRBK $109,758,000.00
- INO $182,337.00
- Revenue This Year
- MRBK $25.14
- INO N/A
- Revenue Next Year
- MRBK $8.08
- INO $14,751.49
- P/E Ratio
- MRBK $8.34
- INO N/A
- Revenue Growth
- MRBK 18.84
- INO N/A
- 52 Week Low
- MRBK $11.16
- INO $1.30
- 52 Week High
- MRBK $17.33
- INO $5.80
- Technical
- Relative Strength Index (RSI)
- MRBK 46.44
- INO 60.39
- Support Level
- MRBK $14.62
- INO $2.44
- Resistance Level
- MRBK $15.79
- INO $2.67
- Average True Range (ATR)
- MRBK 0.55
- INO 0.13
- MACD
- MRBK 0.05
- INO 0.01
- Stochastic Oscillator
- MRBK 46.97
- INO 94.50
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.